Pricing Log in Create free account

Nomad Power Solutions, Inc. (NMAD) vs Verrica Pharmaceuticals Inc. (VRCA)

Nomad Power Solutions, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. Nomad Power Solutions, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($65.9M and $64.9M). Nomad Power Solutions, Inc. has the higher net margin (0.00% vs −102.8%) and the lower return on invested capital (−40.4% vs 0.00%). Across the 13 metrics below, Nomad Power Solutions, Inc. leads on 10 and Verrica Pharmaceuticals Inc. on 3.

Valuation

Metric NMAD VRCA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.49 9.71
P/B 2.09 17.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.56 9.21
Earnings yield (25.77%) (47.18%) (33.15%)
Free cash flow yield (10.44%) (18.02%) (25.50%)

Profitability

Metric NMAD VRCA Biotechnology median
Gross margin — 85.89% 65.16%
Operating margin 0.00% (93.59%) 0.00%
Net margin 0.00% (102.84%) 0.00%
Free cash flow margin 0.00% (44.02%) 0.00%
Return on equity (68.04%) 473.29% (56.36%)
Return on assets (62.67%) (83.02%) (48.04%)
Return on invested capital (40.41%) 0.00% 0.00%

Growth

Metric NMAD VRCA Biotechnology median
Revenue growth (TTM) — 106.21% 6.02%
EPS growth (last fiscal year) 20.75% 88.65% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NMAD VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 12.87 1.45 4.72
Net debt to EBITDA 1.00 2.59 0.96

Dividend

Metric NMAD VRCA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NMAD VRCA Biotechnology median
Market cap 65.85m 64.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack